Name of organisation
1) Department/Research group
2) Organisation/affiliationDrug Safety Research Unit
Short Name in the inventoryDSRU
Administrative Contact
Title Dr
Last name Lynn
First name Elizabeth
Address line 1DSRU
Address line 2Bursledon Hall
Address line 3Blundell Lane
CitySouthampton
PostcodeSO31 1AA
CountryUnited Kingdom
Phone number (incl. country code)44-2380-408600
Alternative phone number
Fax number (incl. country code)44-2380-408609
Scientific Contact
Title Professor
Last name Shakir
First name Saad
Address line 1DSRU
Address line 2Bursledon Hall
Address line 3Blundell Lane
CitySouthampton
PostcodeSO31 1AA
CountryUnited Kingdom
Phone number (incl. country code)44-2380-408600
Alternative phone number
Fax number (incl. country code)United Kingdom
Alternative Scientific Contact
Title Dr
Last name Osborne
First name Vicki
Address line 1DSRU
Address line 2Bursledon Hall
Address line 3Blundell Lane
CitySouthampton
PostcodeSO31 1AA
CountryUnited Kingdom
Phone number (incl. country code)442380408600
Alternative phone number
Fax number (incl. country code)
2. Description
The Drug Safety Research Unit (DSRU) is a leading independent academic research organisation internationally renowned for its work in Prescription Event Monitoring (PEM), Drug Safety and Educational Activities for nearly 30 years.
In partnership with general practitioners in England we aim to protect patients from unwanted adverse effects of newly marketed medicines by way of our unique method of monitoring patients during the early life of a new medicine.
Our research capabilities include PEM, (a systematic active post-marketing surveillance programme), modified PEM, Specialist Cohort Event Monitoring (SCEM) studies, systematic reviews, signal detection, cohort and case control studies, studies for risk management plans, establishment of epidemiological databases, and pharmacogenetics.
The Unit has a team of 12 research fellows (clinicians, epidemiologist, pharmacists and biomedical scientists) who conduct studies, supported by IT, admin and data management staff.
3. Category
Charity or non-profit organisation
4. Available resources
In houseVia Contacts/Network
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Endocrine disorders
Gastrointestinal tract
Immunological products and vaccines
Musculoskeletal and joint diseases
Nutrition and blood
Osteoporosis
Pregnancy
Psychiatry
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 150 and 1499
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
No
In the community
Yes
Electronic data capture systems
Yes
System used:
Bespoke in-house system
Interactive voice response systems
No
Call centre
Yes
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
CPRD5
11. Registries established by centre
Drug RegistryRivaroxaban, seroquel XR, asenapine
Disease RegistryDrug-induced arrhythmias
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Other networks:
Network nameNationalInternationalLink to webpage